SPOP and prostate cancer: Hjoth-Jensen et al. showed that SPOP knockdown reduced the generation of Rad51-positive cells upon camptothecin treatment and inhibited DNA replication in prostate cancer cells and human osteosarcoma U2OS cells [35].